作者: Alan B. Cooper , Yongqi Deng , Liang Zhu , James Wang , Binyuan Sun
DOI:
关键词: Cancer 、 Pyrazole 、 Chemistry 、 Stereochemistry 、 MAPK/ERK pathway
摘要: Disclosed are the ERK inhibitors of Formula (I): (Formula (I)) and pharmaceutically acceptable salts thereof. All substitutents as defined herein. Also disclosed methods treating cancer using compounds (I).